Is Triptorelin FDA approved?
No. This profile records Triptorelin as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Longevity CATEGORY
Triptorelin
THE HORMONE CONTROLLER
Triptorelin Acetate, Triptorelin Pamoate, Decapeptyl
Triptorelin is a powerful GnRH analog used medically to control sex hormone levels. It initially stimulates hormone production but with continued use causes the pituitary to downregulate, dramatically reducing testosterone or estrogen. It's FDA-approved for prostate cancer, endometriosis, precocious puberty, and gender-affirming care.
Triptorelin
Triptorelin
Triptorelin
Triptorelin Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Triptorelin
What dose does The Peptide App Clinical Team recommend for Triptorelin?
Dose: 3.75 mg intramuscularly monthly.
MORE CONTEXT ›
Schedule: daily. Cycle: 3+ months (medical supervision required). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Triptorelin guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
GnRH Receptor Downregulation
Continuous stimulation causes receptor internalization and hormone suppression
Gonadotropin Suppression
Halts LH and FSH production, stopping downstream hormone synthesis
Sex Steroid Reduction
Creates hypogonadal state beneficial for hormone-sensitive conditions
Men with hormone-sensitive prostate cancer
Women with endometriosis or uterine fibroids
Children with central precocious puberty
Transgender individuals seeking hormone suppression
Bodybuilders recovering from steroid cycles (under supervision)
Triptorelin Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES